CLOV CLOVER HEALTH INV CORP

Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022

Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022

FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 9:10 a.m. Eastern Time.

A live webcast of the presentation will be accessible from Clover Health's investor relations website at . An archived replay of the presentation will be available from the same website for 12 months following the live presentation.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states. Our Non-Insurance line of business offers a variety of programs aimed at reducing expenditures and enhancing the quality of care for patients enrolled in fee-for-service Medicare. Clover’s corporate headquarters are in Franklin, Tenn.

Press Contact:

Andrew Still-Baxter

Investor Relations Contacts:

Ryan Schmidt



Steve Halper



EN
31/08/2022

Underlying

CLOVCLOVER HEALTH INV CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Reports First Quarter 2025 Results and Improves Full Yea...

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjust...

May 6, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Primary Care Physician Use of Counterpart Assistant Technology Associa...

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions (25% lower) in heart failure patients WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Heal...

May 1, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Announces Changes to Board of Directors

Clover Health Announces Changes to Board of Directors Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders’ Meeting WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s Board of Directors, has notified the Company of his intention not to stand for ...

April 22, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming Investor Conferences

Clover Health to Participate in Upcoming Investor Conferences WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will present at the 2025 Bank of America Healthcare Conference on Wednesday, May 14, 2025, at 6:00 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at .CFO, Peter Kuipers, will participate in the 22nd Annual C...

April 21, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Report First Quarter 2025 Financial Results on May 6,...

Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025 WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 6, 2025, to discuss Clover Health’s first quarter 2025 business and financial results. First Quarter 2025 Conference Call and Webcast Details: What: Clover Health’s Firs...

April 8, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch